
Clotide 0.75mg/ml Infusion
Marketer
Biocon
Salt Composition
Eptifibatide (0.75mg/ml)
Overview Clotide 0.75mg/ml Infusion
CardioGen 0.75mg/ml infusion is an anticoagulant preventing the development of dangerous blood clots. It's employed in acute myocardial infarction treatment and to inhibit clot formation during cardiac angioplasty (a procedure enhancing coronary blood flow). CardioGen 0.75mg/ml infusion is administered under strict medical supervision. Dosage and treatment length are determined individually by your physician. Continue all other prescribed medications as directed, even following this infusion. Thrombocytopenia (low platelet count) and increased bleeding risk are potential adverse effects. Report any petechiae (pinpoint rash) or blood in bodily fluids (vomit, urine, stool) immediately. Hypotension (low blood pressure) is another possible side effect. Your doctor will discuss the risks and benefits before administration. Caution is warranted in certain patients. Before commencing treatment, disclose any bleeding disorders, hepatic or renal impairment, pregnancy, breastfeeding, and all other concurrent medications.
Uses of Clotide 0.75mg/ml Infusion
Thrombosis prophylaxis | Myocardial infarction prevention
Major Benefits of Clotide 0.75mg/ml Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Clotide 0.75mg/ml Infusion:
- Bleeding
- Decreased blood pressure
How to use Clotide 0.75mg/ml Infusion:
This medication will be administered by your healthcare provider. Self-medication is not advised.
How Clotide 0.75mg/ml Infusion works:
Clotide 0.75mg/ml infusion is an antithrombotic agent that inhibits platelet aggregation, thus reducing the risk of dangerous thrombus development.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Clotide 0.75mg/ml Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
Administration of Clotide 0.75mg/ml infusion is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no negative impacts on fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
Administration of Clotide 0.75mg/ml Infusion necessitates careful consideration in breastfeeding mothers. Lactation should be temporarily discontinued throughout the mother's treatment course and until complete drug clearance.
DrivingNOT RELEVANT
Clotide 0.75mg/ml infusion is administered exclusively in a hospital setting.
KidneyCAUTION
Exercise caution when administering Clotide 0.75mg/ml Infusion to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Clotide 0.75mg/ml Infusion is contraindicated in patients exhibiting severe kidney disease.
LiverCONSULT YOUR DOCTOR
Data on Clotide 0.75mg/ml Infusion use in patients with hepatic impairment is scarce. Physician consultation is advised. Clotide 0.75mg/ml Infusion is contraindicated in patients exhibiting severe liver dysfunction.
What if you forget to take Clotide 0.75mg/ml Infusion :
Omit a Clotide 0.75mg/ml Infusion dose? Seek your physician's advice.
Facts to Know About Clotide 0.75mg/ml Infusion
| Label | Value |
|---|---|
| Type of Compound | Amino acid and peptide mimetics |
| Potential for Dependence | None. |
| Type of Treatment | Hematological |
| Mechanism of Action | IIb/IIIa receptor antagonists |
